"10.1371_journal.pone.0117484","plos one","2015-02-23T00:00:00Z","Juan M Rodriguez; José Marchicio; Mariela López; Andrea Ziblat; Fernanda Elias; Juan Fló; Ricardo A López; David Horn; Jorge Zorzopulos; Alejandro D Montaner","Fundación Pablo Cassará, Buenos Aires, Argentina; Immunotech S.A., Buenos Aires, Argentina; David Horn LLC, Doylestown, Pennsylvania, United States of America; Instituto de Ciencia y Tecnología Dr. Cesar Milstein, Buenos Aires, Argentina","Conceived and designed the experiments: JMR JF JZ ADM. Performed the experiments: JMR JM ML AZ FE. Analyzed the data: JMR RAL JZ ADM. Contributed reagents/materials/analysis tools: DH. Wrote the paper: JZ ADM.","JM, ML, AZ, FE, JF, RAL and JZ are employees of Immunotech S.A., whose company provided funding towards this study. DH is the CEO of Mid-Atlantic BioTherapeutics, Inc. and a principal of David Horn, LLC, which is responsible for the IMT504 patent estate. Patent name and number: EP 1 511 845 B1. Immunostimulatory oligonucleotides and uses thereof. International application number: PCT/EP2003/005691. International publication number: WO 2003/101375. US7943316 (B2). There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2015","02","Juan M Rodriguez","JMR",10,TRUE,4,5,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
